LMR Partners’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
Other funds holding NAMS
DFO
LMR Partners's NAMS Position: Q3 2026 in Review
LMR Partners opened a new position in NewAmsterdam Pharma (NAMS) in Q3 2026: 36,458 shares worth $887K. The stake represents ﹤0.01% of the portfolio and ranks #1119 among its holdings.
183 funds tracked by Wall St. Rank hold NAMS as of Q3 2026.
- LMR Partners held 36,458 shares of NewAmsterdam Pharma worth $887K as of Q3 2026.
- NewAmsterdam Pharma was a new LMR Partners position in Q3 2026.
- NewAmsterdam Pharma made up ﹤0.01% of LMR Partners's portfolio in Q3 2026, its #1119 holding.
- 183 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q3 2026.
Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.